Docusign Set to Report Q1 Earnings: Buy, Sell or Hold the Stock?

Ahead of its Q1 earnings report, Docusign (DOCU) faces uncertainty despite a 67.7% stock increase over the past year, outperforming its industry. While revenue is projected to grow 5.3% year-over-year to $747 million, EPS is expected to decline 1.2% to $0.81, and a new AI-powered product, IAM, shows promise but faces questions regarding adoption and monetization; coupled with a weak liquidity position (current ratio of 0.81), Zacks suggests investors consider selling DOCU shares.

Analysis

Docusign (DOCU) presents a complex investment profile ahead of its upcoming Q1 earnings. Despite a significant 67.7% share price increase over the past year, outperforming its industry and the S&P 500, several underlying concerns temper enthusiasm. The Zacks Consensus Estimate anticipates Q1 revenue growth of 5.3% year-over-year to $747 million, primarily driven by a projected 5.7% rise in subscription revenues to $730.8 million. This growth is partly attributed to the adoption of the new AI-powered Intelligent Agreement Management (IAM) product, which reportedly contributed over 20% to direct sales in the fourth quarter of fiscal 2025. However, this top-line expansion is overshadowed by an expected 1.2% year-over-year decline in earnings per share to $0.81, alongside a concerning 11.4% YoY fall in professional services and other revenues to $16.1 million. Compounding these concerns, Zacks' proprietary model does not predict an earnings beat, assigning DOCU an Earnings ESP of 0.00% and a Zacks Rank #4 (Sell), with one earnings estimate having been revised downwards in the last 60 days. Critical challenges include the nascent stage of the IAM product, raising questions about scalable adoption and effective monetization, particularly within a potentially recessionary macroeconomic climate that could curb tech investments. Furthermore, Docusign's liquidity position is notably weak, with a current ratio of 0.81 reported for Q4 fiscal 2025, substantially below the industry average of 2.38 and the critical benchmark of 1, indicating potential difficulties in meeting short-term financial obligations. While DOCU's trailing 12-month P/E ratio of 24.96X is below the industry's 37.6X, the combination of deteriorating earnings projections and liquidity issues presents considerable downside risk.

Key Decisions for Investors

• Given Docusign's substantial year-long stock appreciation against a backdrop of projected Q1 earnings decline, a Zacks Rank #4 (Sell), and a concerning current ratio of 0.81, existing investors should consider evaluating their positions to potentially secure profits.
• Prospective investors are advised to exercise significant caution, carefully weighing the uncertainties surrounding the new IAM product's large-scale adoption and monetization strategy against the backdrop of macroeconomic headwinds and the company's weak liquidity.
• Investors should closely monitor the upcoming Q1 earnings report for concrete data on IAM's revenue contribution, management's commentary on addressing the 0.81 current ratio, and any revisions to guidance, as these factors will be critical in assessing the stock's trajectory.